VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gene Voss who wrote (2581)	11/18/1997 5:36:00 AM
From: BigKNY3	Read Replies (2) of 23519

Gene: <<To believe this or any agent is innocous is ridiculous.>> Gene, how do explain the summary data of the Viagra clinical studies that is currently being reviewed by the FDA and made public by Pfizer? The database of 4,500 men (including 550 patients who received Viagra for over a year) indicated the following: -"The discontinuation rates due to side effects are low, similar to placebo". -"There are no reports of priapism." -"The most common side effects were mild headache and flushing." Based on a review of this summary data, a very influential and respected pharmaceutical stock analyst concluded: "Viagra efficacy is impressive and side effects are unusally low." BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next